Company: ARTL
Filing Date: 2025-09-04
Form Type: 424B5
Source: 0001640334-25-001624
Chunk: 31

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-09-04
Form: 424B5
Chunk 31
---
 of Common Stock |     | Per  Pre-funded Warrant |     | Total with  no Over-Allotment |     | Total with  Over-Allotment |
|:---------------------------------|:----|:---------------------------|:----|:------------------------|:----|:------------------------------|:----|:---------------------------|
| Public offering price            |     | $                          |     | $                       |     | $                             |     | $                          |
| Underwriting discount (7%)       |     | $                          |     | $                       |     | $                             |     | $                          |
| Proceeds, before expenses, to us |     | $                          |     | $                       |     | $                             |     | $                          |
|                                  |     | $                          |     | $                       |     | $                             |     | $                          |

Expenses

We have agreed to pay or reimburse the underwriter for certain of its out-of-pocket expenses relating to the offering, including up to $100,000 for the fees and expenses of the underwriter’s outside legal counsel, the underwriter’s actual accountable “road show” expenses for the offering, the costs associated with receiving commemorative mementos and lucite tombstones, the costs of the underwriter’s use of book-building, prospectus tracking and compliance software, and fees, expenses and disbursements relating to background checks of our officers and directors. We estimate that our total expenses of the offering, excluding underwriting discounts and commissions, will be approximately $[ ].

Right of First Refusal

We shall grant R.F. Lafferty & Co., Inc. a right of first refusal to act as sole and exclusive investment banker, book-runner, financial advisor, underwriter and/or placement agent, for each and every future public and private equity and debt offering, including all equity linked financings, for our Company, or any successor to or any subsidiary of our Company, until December 31, 2025.

Lock-up Agreements

We have agreed with the underwriter that we will not, subject to certain exceptions, without the prior consent of R.F. Lafferty & Co., Inc. (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of our capital stock or any securities convertible into or exercisable or exchange